Stocks got a boost from a report showing inflation at the U.S. wholesale level wasn’t as high last month as expected. Lilly ...
The S&P 500 added 0.1% on Tuesday, Jan. 14, as tame wholesale inflation data provided a positive signal ahead of Wednesday's ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...
U.S. stock futures point higher ahead of closely watched CPI report, JPMorgan Chase stock rises on better-than-expected ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
NEW YORK (AP) — Most U.S. stocks are rising Tuesday following an encouraging update on inflation, but drops for Eli Lilly and some other influential stocks are keeping indexes in check.
We recently published a list of Jim Cramer Discussed These 18 Stocks As Inflation Dropped. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...